Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).

Al-Kali A, Wierda W, Keating M, O'Brien S

Open source

DOI
10.2147/jbm.s7138
Published
2010
Container
Journal of blood medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jbm.s7138,
  title = {Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).},
  author = {Al-Kali A and Wierda W and Keating M and O'Brien S},
  year = {2010},
  journal = {Journal of blood medicine},
  doi = {10.2147/jbm.s7138},
  url = {https://doi.org/10.2147/jbm.s7138}
}

RIS

TY  - JOUR
TI  - Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).
AU  - Al-Kali A
AU  - Wierda W
AU  - Keating M
AU  - O'Brien S
PY  - 2010
JO  - Journal of blood medicine
DO  - 10.2147/jbm.s7138
UR  - https://doi.org/10.2147/jbm.s7138
ER  - 

APA

A, A., W, W., M, K., & S, O. (2010). Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).. Journal of blood medicine. https://doi.org/10.2147/jbm.s7138

Source records